Urinary 2-ethyl-3-oxohexanoic acid as major metabolite of orally administered 2-ethylhexanoic acid in human
✍ Scribed by Dana Stingel; Peter Feldmeier; Elke Richling; Michael Kempf; Sandra Elss; Samira Labib; Peter Schreier
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 536 KB
- Volume
- 51
- Category
- Article
- ISSN
- 1613-4125
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Human metabolism of 2‐ethylhexanoic acid (2‐EHA), which is a known metabolite of important phthalates, was investigated using 2‐EHA‐contaminated food. The results of our studies reveal that the major catabolic pathway of 2‐EHA in human is β‐oxidation. The dominant final urinary metabolite was identified and quantified as 3‐oxo‐2‐ethylhexanoic acid (3‐oxo‐2‐EHA), but only after immediate methylation of the extract from urine and prior to GC‐MS analysis. Former studies without the precaution of immediate methylation had found 4‐heptanone as the major metabolite, which is obviously an artifact arising from the decarboxylation of 3‐oxo‐2‐EHA.
📜 SIMILAR VOLUMES
The heptafluorobutyryl derivatives of some steroid standards were analyzed on a 25 m X 0.32 mm OV-1 fused silicacolumn. The effluent was split in the ratio : FID 5 : ECD 1 by using split arms of 20 cm X 0.32 mm ID and 20 X 0.25 mm ID respectively. Make-up gas was nitrogen with a flow-rate of 22 ml m
A system for the assay of the major metabolite of E prostaglandins (PGE-M) in human urine was developed. The metabolite, as the dimethyl ester-bis(O-methyloxime)-trimethylsilyl ether derivative, was quantified by gas chromatography-mass spectrometry with selected ion monitoring. The internal standar